176 related articles for article (PubMed ID: 23665474)
1. A distant, cis-acting enhancer drives induction of Arf by Tgfβ in the developing eye.
Zheng Y; Devitt C; Liu J; Mei J; Skapek SX
Dev Biol; 2013 Aug; 380(1):49-57. PubMed ID: 23665474
[TBL] [Abstract][Full Text] [Related]
2. p19Arf represses platelet-derived growth factor receptor β by transcriptional and posttranscriptional mechanisms.
Widau RC; Zheng Y; Sung CY; Zelivianskaia A; Roach LE; Bachmeyer KM; Abramova T; Desgardin A; Rosner A; Cunningham JM; Skapek SX
Mol Cell Biol; 2012 Nov; 32(21):4270-82. PubMed ID: 22907756
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Arf tumor suppressor gene is controlled by Tgfbeta2 during development.
Freeman-Anderson NE; Zheng Y; McCalla-Martin AC; Treanor LM; Zhao YD; Garfin PM; He TC; Mary MN; Thornton JD; Anderson C; Gibbons M; Saab R; Baumer SH; Cunningham JM; Skapek SX
Development; 2009 Jun; 136(12):2081-9. PubMed ID: 19465598
[TBL] [Abstract][Full Text] [Related]
4. Tgfbeta signaling directly induces Arf promoter remodeling by a mechanism involving Smads 2/3 and p38 MAPK.
Zheng Y; Zhao YD; Gibbons M; Abramova T; Chu PY; Ash JD; Cunningham JM; Skapek SX
J Biol Chem; 2010 Nov; 285(46):35654-64. PubMed ID: 20826783
[TBL] [Abstract][Full Text] [Related]
5. p19(Arf) limits primary vitreous cell proliferation driven by PDGF-B.
Iqbal NS; Devitt CC; Sung CY; Skapek SX
Exp Eye Res; 2016 Apr; 145():224-229. PubMed ID: 26778750
[TBL] [Abstract][Full Text] [Related]
6. miR-34a is essential for p19(Arf)-driven cell cycle arrest.
Iqbal N; Mei J; Liu J; Skapek SX
Cell Cycle; 2014; 13(5):792-800. PubMed ID: 24401748
[TBL] [Abstract][Full Text] [Related]
7. Arf induction by Tgfβ is influenced by Sp1 and C/ebpβ in opposing directions.
Zheng Y; Devitt C; Liu J; Iqbal N; Skapek SX
PLoS One; 2013; 8(8):e70371. PubMed ID: 23940569
[TBL] [Abstract][Full Text] [Related]
8. Identification of
Liu YT; Xu L; Bennett L; Hooks JC; Liu J; Zhou Q; Liem P; Zheng Y; Skapek SX
Mol Cancer Res; 2019 Sep; 17(9):1854-1866. PubMed ID: 31189690
[TBL] [Abstract][Full Text] [Related]
9. The Arf tumor suppressor regulates platelet-derived growth factor receptor beta signaling: a new view through the eyes of Arf(-/-) mice.
Thornton JD; Silva RL; Martin AC; Skapek SX
Cell Cycle; 2005 Oct; 4(10):1316-9. PubMed ID: 16205116
[TBL] [Abstract][Full Text] [Related]
10. Testis-specific Arf promoter expression in a transposase-aided BAC transgenic mouse model.
Sung CY; Liu YT; Bennett LB; Devitt CC; Skapek SX
Mol Biol Rep; 2019 Dec; 46(6):6243-6252. PubMed ID: 31583563
[TBL] [Abstract][Full Text] [Related]
11. Varied manifestations of persistent hyperplastic primary vitreous with graded somatic mosaic deletion of a single gene.
Mary-Sinclair MN; Wang X; Swanson DJ; Sung CY; Mendonca EA; Wroblewski K; Baumer SH; Goldowitz D; Jablonski MM; Skapek SX
Mol Vis; 2014; 20():215-30. PubMed ID: 24623965
[TBL] [Abstract][Full Text] [Related]
12. Arf-dependent regulation of Pdgf signaling in perivascular cells in the developing mouse eye.
Silva RL; Thornton JD; Martin AC; Rehg JE; Bertwistle D; Zindy F; Skapek SX
EMBO J; 2005 Aug; 24(15):2803-14. PubMed ID: 16037818
[TBL] [Abstract][Full Text] [Related]
13. Persistent hyperplastic primary vitreous due to somatic mosaic deletion of the arf tumor suppressor.
Thornton JD; Swanson DJ; Mary MN; Pei D; Martin AC; Pounds S; Goldowitz D; Skapek SX
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):491-9. PubMed ID: 17251441
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.
Martin AC; Thornton JD; Liu J; Wang X; Zuo J; Jablonski MM; Chaum E; Zindy F; Skapek SX
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3387-96. PubMed ID: 15452040
[TBL] [Abstract][Full Text] [Related]
15. The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.
McKeller RN; Fowler JL; Cunningham JJ; Warner N; Smeyne RJ; Zindy F; Skapek SX
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3848-53. PubMed ID: 11891301
[TBL] [Abstract][Full Text] [Related]
16. Isolation and characterization of mammalian cells expressing the Arf promoter during eye development.
Iqbal NS; Xu L; Devitt CC; Skapek SX
Biotechniques; 2014 May; 56(5):239-49. PubMed ID: 24806224
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice.
Visel A; Zhu Y; May D; Afzal V; Gong E; Attanasio C; Blow MJ; Cohen JC; Rubin EM; Pennacchio LA
Nature; 2010 Mar; 464(7287):409-12. PubMed ID: 20173736
[TBL] [Abstract][Full Text] [Related]
18. Methyltransferase Inhibition Enables Tgf
Liu YT; Romero C; Xiao X; Guo L; Zhou X; Applebaum MA; Xu L; Skapek SX
Mol Cell Biol; 2023; 43(3):115-129. PubMed ID: 36941772
[No Abstract] [Full Text] [Related]
19. Transient expression of the Arf tumor suppressor during male germ cell and eye development in Arf-Cre reporter mice.
Gromley A; Churchman ML; Zindy F; Sherr CJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6285-90. PubMed ID: 19339492
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesis.
Inoue K; Wen R; Rehg JE; Adachi M; Cleveland JL; Roussel MF; Sherr CJ
Genes Dev; 2000 Jul; 14(14):1797-809. PubMed ID: 10898794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
